ARIEL GRAFF GUERRERO



DATOS GENERALES
Nombre completo   ARIEL GRAFF GUERRERO
Máximo nivel de estudios   DOCTORADO
Antigüedad académica en la UNAM   3 años
NOMBRAMIENTOS
Último  INVESTIGADOR ASOCIADO C TC No Definitivo
Instituto de Neurobiología en Querétaro, Querétaro
INVESTIGADOR ASOCIADO C TC No Definitivo
Instituto de Neurobiología en Querétaro, Querétaro
Desde 01-01-2008 (fecha inicial de registros en el SIIA) hasta 15-10-2009
ESTIMULOS, PROGRAMAS, PREMIOS Y RECONOCIMIENTOS
* SNI III2016 - 2023
* SNI II2012 - 2015
* SNI I - 2011

INFORMACIÓN DE PUBLICACIONES
Firmas  
Graff A. Graff, A. Graff-Guerrero A. Graff-Guerrero, A Graff-Guerrero, A. Graff-Guerrero, Ariel
Guerrero A.G.
ID's SCOPUS  
6603448226
ORCID's  
0000-0001-9301-2171
Áreas de conocimiento  
Behavioral sciences Biochemistry and molecular biology Clinical neurology Computer science, artificial intelligence Computer science, theory & methods
Chemistry, multidisciplinary Chemistry, organic Gerontology Health policy and services Jcs 2008
Medical laboratory technology Medicine, general & internal Medicine, general and internal Medicine, research and experimental Multidisciplinary sciences
Neuroimaging Neurosciences Nutrition and dietetics Ophthalmology Pharmacology & pharmacy
Pharmacology and pharmacy Psychiatry Psychology Psychology, clinical Psychology, experimental
Psychology, multidisciplinary Psychology, social Public, environmental and occupational health Radiology, nuclear medicine & medical imaging Radiology, nuclear medicine and medical imaging
Scie jcr Ssci jcr Substance abuse Toxicology Agricultural and biological sciences (miscellaneous)
Anesthesiology and pain medicine Arts and Humanities (miscellaneous) Behavioral neuroscience Biochemistry (medical) Biological Psychiatry
Cellular and Molecular Neuroscience Clinical psychology Cognitive neuroscience Computer Science (miscellaneous) Computer Science Applications
Development Food science Geriatrics and gerontology Health (social science) Leadership and management
Medicine (miscellaneous) Multidisciplinary Neurology Neurology (clinical) Neuropsychology and physiological psychology
Neuroscience (miscellaneous) Ophthalmology Pharmaceutical Science Pharmacology Pharmacology (medical)
Psychiatry and Mental Health Psychology (miscellaneous) Public health, environmental and occupational health Radiological and ultrasound technology Radiology, nuclear medicine and imaging
Sociology and political science Toxicology
Coautorías con entidades de la UNAM  
  • Instituto de Neurobiología en Querétaro, Querétaro
Revistas en las que ha publicado  (84):
  1. ACTA NEUROLOGICA SCANDINAVICA, Dinamarca (2004)
  2. ACTA PSYCHIAT SCAND, Reino Unido (2021)
  3. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, Estados Unidos America (2018)
  4. AM J PSYCHIAT, Estados Unidos America (2007, 2017)
  5. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, Estados Unidos America (2009, 2012, 2014, 2016, 2017, 2021)
  6. ANALES DE PSICOLOGIA, España (2021)
  7. ARCH GEN PSYCHIAT, Estados Unidos America (2009)
  8. BEHAVIOURAL NEUROLOGY, Estados Unidos America (2016)
  9. BIOLOGICAL PSYCHIATRY, Estados Unidos America (2007, 2008, 2009, 2011, 2015, 2018, 2019)
  10. BIOORGANIC & MEDICINAL CHEMISTRY, Reino Unido (2012)
  11. BMC MEDICAL IMAGING, Reino Unido (2009)
  12. Brain, Reino Unido (2017)
  13. BRAIN IMAGING AND BEHAVIOR, Estados Unidos America (2019)
  14. BRIT J PSYCHIAT, Reino Unido (2011, 2018)
  15. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, Estados Unidos America (2022)
  16. CLINICA CHIMICA ACTA, Países Bajos (2015)
  17. COGNITIVE BRAIN RES, (2005)
  18. CURRENT ALZHEIMER RESEARCH, (2019)
  19. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, Países Bajos (2020)
  20. DRUG AGING, Nueva Zelanda (2011)
  21. DRUG AND ALCOHOL DEPENDENCE, Irlanda (2021, 2022)
  22. EUROPEAN NEUROPSYCHOPHARMACOLOGY, Países Bajos (2013, 2014, 2016, 2022)
  23. EUROPEAN PSYCHIATRY, Francia (2019)
  24. EXPERIMENTAL EYE RESEARCH, Estados Unidos America (2018)
  25. Frontiers In Medicine, Suiza (2021)
  26. FRONTIERS IN PHARMACOLOGY, Suiza (2014)
  27. Frontiers in Psychiatry, Suiza (2018)
  28. GACETA MEDICA DE MEXICO, México (2009)
  29. GERIATRICS & GERONTOLOGY INTERNATIONAL, Estados Unidos America (2019)
  30. Healthcare, Suiza (2022)
  31. HUMAN BRAIN MAPPING, Estados Unidos America (2008, 2013, 2015, 2017)
  32. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, Estados Unidos America (2011, 2013, 2014, 2017, 2018)
  33. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, Suiza (2016)
  34. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, Estados Unidos America (2008, 2009, 2010, 2013, 2015)
  35. International Journal Of Psychology And Psychological Therapy, España (2014)
  36. J CLIN PSYCHOPHARM, Estados Unidos America (2009, 2011)
  37. J GAMBL STUD, Estados Unidos America (2020)
  38. J GERIATR PSYCH NEUR, Estados Unidos America (2015)
  39. J PSYCHIATR NEUROSCI, Canada (2022)
  40. J PSYCHOPHARMACOL, Reino Unido (2018, 2019)
  41. JAMA PSYCHIATRY, Estados Unidos America (2013, 2014, 2015, 2021)
  42. Japanese Journal of Psychopharmacology, Japón (2014)
  43. JOURNAL OF AFFECTIVE DISORDERS, Países Bajos (2004, 2008)
  44. JOURNAL OF ALZHEIMERS DISEASE, Países Bajos (2014, 2015, 2016, 2017, 2018, 2020, 2022)
  45. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, Estados Unidos America (2007, 2015)
  46. JOURNAL OF CLINICAL PSYCHIATRY, Estados Unidos America (2016, 2017)
  47. JOURNAL OF ECT, Estados Unidos America (2011)
  48. JOURNAL OF NEUROIMAGING, Estados Unidos America (2019)
  49. JOURNAL OF NEUROSCIENCE RESEARCH, Estados Unidos America (2021)
  50. JOURNAL OF OBSESSIVE-COMPULSIVE AND RELATED DISORDERS, Países Bajos (2021)
  51. JOURNAL OF PAIN RESEARCH, Nueva Zelanda (2022)
  52. JOURNAL OF PSYCHIATRIC RESEARCH, Reino Unido (2012, 2013, 2019, 2020, 2021)
  53. Lecture Notes in Computer Science, Suiza (2014)
  54. MEDICAL HYPOTHESES, Reino Unido (2015, 2017, 2018)
  55. MOLECULAR PSYCHIATRY, Reino Unido (2015, 2019, 2022)
  56. Neurocase, Estados Unidos America (2013)
  57. Neuroimage, Estados Unidos America (2005, 2007)
  58. Neuropharmacology, Reino Unido (2020)
  59. NEUROPSYCH DIS TREAT, Nueva Zelanda (2011)
  60. Neuropsychologia, Reino Unido (2018)
  61. NEUROPSYCHOPHARMACOLOGY, Reino Unido (2008, 2009, 2010, 2011, 2012, 2014, 2016, 2019, 2020)
  62. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, Reino Unido (2018, 2022)
  63. NEUROSCIENCE LETTERS, Irlanda (2016)
  64. NEUROSCIENCE RESEARCH, Irlanda (2019)
  65. NEUROTOXICOLOGY AND TERATOLOGY, Reino Unido (1999)
  66. NICOTINE TOB RES, Reino Unido (2022)
  67. Npj Schizophrenia, Alemania (2019, 2021)
  68. Nutrients, Suiza (2020)
  69. PERSONALITY AND INDIVIDUAL DIFFERENCES, Reino Unido (2014)
  70. Pharmacopsychiatry, Alemania (2015)
  71. PLOS ONE, Estados Unidos America (2018, 2021)
  72. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, Reino Unido (2013, 2014, 2016, 2018, 2019, 2020, 2022)
  73. PSYCHIATRY RESEARCH, Irlanda (2012, 2014, 2017, 2018)
  74. PSYCHIATRY RESEARCH-NEUROIMAGING, Países Bajos (2010, 2017, 2018)
  75. PSYCHONEUROENDOCRINOLOGY, Reino Unido (2017)
  76. Psychopharmacology, Estados Unidos America (2013, 2015, 2016)
  77. REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, México (2001)
  78. REVISTA MEXICANA DE PSICOLOGIA, México (2018)
  79. SALUD MENTAL, México (2001, 2002, 2004, 2007)
  80. SCHIZOPHRENIA BULLETIN, Estados Unidos America (2009, 2013, 2015, 2016, 2017)
  81. SCHIZOPHRENIA RESEARCH, Países Bajos (2007, 2009, 2011, 2013, 2014, 2015, 2016, 2019, 2020, 2022)
  82. SOCIAL NEUROSCIENCE, Reino Unido (2010, 2017)
  83. Synapse, Estados Unidos America (2016, 2017, 2020, 2021)
  84. TRANSLATIONAL PSYCHIATRY, Estados Unidos America (2021)


Descargar PDF

Documentos indexados (WoS y Scopus)

# Título del documento Autores Año Revista Fuente Citas WoS Citas Scopus
1Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studiesCoautor: Graff-Guerrero A., Nakahara T., Tsugawa S., Noda Y., et al.2022MOLECULAR PSYCHIATRYWoS-id: 000701629800002
Scopus-id: 2-s2.0-85115884429
7978
2Striatal glutamate, subcortical structure and clinical response to first-line treatment in first-episode psychosis patientsCoautor: Graff-Guerrero A., Reyes-Madrigal F., Guma E., León-Ortiz P., et al.2022PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRYWoS-id: 000719909100003
Scopus-id: 2-s2.0-85122508580
1011
3Investigating structural subdivisions of the anterior cingulate cortex in schizophrenia, with implications for treatment resistance and glutamatergic levelsCoautor: Graff-Guerrero A., Ochi R., Plitman E., Patel R., et al.2022J PSYCHIATR NEUROSCIWoS-id: 000744342900001
Scopus-id: 2-s2.0-85123192884
1415
4A Measure of Illness Awareness in Individuals with Nicotine Dependence-Nicotine Use Awareness and Insight ScaleCoautor: Graff-Guerrero A., Kim J., Kambari Y., Taggar A., et al.2022NICOTINE TOB RESWoS-id: 000756821400001
Scopus-id: 2-s2.0-85122813559
23
5Neuromelanin accumulation in patients with schizophrenia: A systematic review and meta-analysisCoautor: Graff-Guerrero A., Ueno F., Iwata Y., Nakajima S., et al.2022NEUROSCIENCE AND BIOBEHAVIORAL REVIEWSWoS-id: 000762200000006
Scopus-id: 2-s2.0-85118747623
1919
6MAP Bayesian modelling combining striatal dopamine receptor occupancy and plasma concentrations to optimize antipsychotic dose regimens in individual patientsCoautor: Graff-Guerrero A., Ismail M., Straubinger T., Uchida H., et al.2022BRITISH JOURNAL OF CLINICAL PHARMACOLOGYWoS-id: 000762441000001
Scopus-id: 2-s2.0-85125373477
22
7The Rationale and Design of Behavioral Interventions for Management of Agitation in Dementia in a Multi-Site Clinical TrialCoautor: Graff-Guerrero A., Zarei S., Colman S., Rostas A., et al.2022JOURNAL OF ALZHEIMERS DISEASEWoS-id: 000773411100026
Scopus-id: 2-s2.0-85128001360
12
8Tracking the Temporal Footprint Effect of Thermonociception and Denervation on the Brain's Pain Matrix: fMRI and BOLD Study in RatsCoautor: Graff-Guerrero, Ariel, Pellicer, Francisco, Ortega-Legaspi, Juan M., Martin, Rodrigo, et al.2022JOURNAL OF PAIN RESEARCHWoS-id: 000779842800005
Scopus-id: 2-s2.0-85128044112
00
9Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatmentCoautor: Graff-Guerrero A., Wada M., Noda Y., Iwata Y., et al.2022MOLECULAR PSYCHIATRYWoS-id: 000784824500001
Scopus-id: 2-s2.0-85128444952
4648
10A measure of subjective substance use disorder awareness ? Substance Use Awareness and Insight Scale (SAS)Coautor: Graff-Guerrero A., Kim J., Kambari Y., Taggar A., et al.2022DRUG AND ALCOHOL DEPENDENCEWoS-id: 000787246600033
Scopus-id: 2-s2.0-85122806201
109
11Decision tree classification of cognitive functions with D2 receptor occupancy and illness severity in late-life schizophreniaCoautor: Graff-Guerrero A., Kusudo K., Ochi R., Nakajima S., et al.2022SCHIZOPHRENIA RESEARCHWoS-id: 000790821600020
Scopus-id: 2-s2.0-85123764721
22
12Differential Methylation Analysis of Suicidal Ideation Severity in Schizophrenia with the Illumina MethylationEPIC ArrayCoautor: Graff-Guerrero A., Wang K.Z., Chaudhary Z., Qian J., et al.2022HealthcareWoS-id: 000802571400001
Scopus-id: 2-s2.0-85129584505
11
13Childhood trauma exposure and personality traits in schizophrenia patientsCoautor: Graff-Guerrero A., Adanty C., Qian J., Wang Y., et al.2022SCHIZOPHRENIA RESEARCHWoS-id: 000812325300011
Scopus-id: 2-s2.0-85124430669
55
14Investigation of accelerated epigenetic aging in individuals suffering from schizophrenia in the context of lifetime suicide attemptCoautor: Graff-Guerrero A., Jeremian R., Bani-Fatemi A., Strauss J.S., et al.2022SCHIZOPHRENIA RESEARCHWoS-id: 000816964000002
Scopus-id: 2-s2.0-85066437115
23
15The effects of acute dopamine depletion on resting-state functional connectivity in healthy humansCoautor: Graff-Guerrero A., Caravaggio F., Barnett A.J., Nakajima S., et al.2022EUROPEAN NEUROPSYCHOPHARMACOLOGYWoS-id: 000820099600005
Scopus-id: 2-s2.0-85123736623
54
16Graph theory analysis of the dopamine D2 receptor network in Parkinson?s disease patients with cognitive declineCoautor: Graff-Guerrero A., Mihaescu A.S., Kim J., Masellis M., et al.2021JOURNAL OF NEUROSCIENCE RESEARCHWoS-id: 000595239000001
Scopus-id: 2-s2.0-85097031532
68
17Measuring amphetamine-induced dopamine release in humans: A comparative meta-analysis of [11C]-raclopride and [11C]-(+)-PHNO studiesCoautor: Graff-Guerrero A., Caravaggio F., Porco N., Kim J., et al.2021SynapseWoS-id: 000613316700001
Scopus-id: 2-s2.0-85100032523
1010
18Propiedades psicométricas de la escala de gaudibilidad (Moduladores de disfrute) para niños y adolescentes (EGNA)Coautor: Graff-Guerrero A., Padrós-Blázquez F., Martinez-Medina M.P., Guardia-Olmos J.2021ANALES DE PSICOLOGIAWoS-id: 000614255300009
Scopus-id: 2-s2.0-85098976768
13
19Lower striatal dopamine D2/3receptor availability in obsessive-compulsive disorder: A meta-analysis of [11C]-raclopride and [123I]-IBZM studiesCoautor: Graff-Guerrero A., Caravaggio F., Porco N., Iwata Y., et al.2021JOURNAL OF OBSESSIVE-COMPULSIVE AND RELATED DISORDERSWoS-id: 000624898300017
Scopus-id: 2-s2.0-85098121330
11
20Structural Brain Differences Between Cognitively Impaired Patients With and Without ApathyCoautor: Graff-Guerrero A., Chan N.K., Gerretsen P., Chakravarty M.M., et al.2021AMERICAN JOURNAL OF GERIATRIC PSYCHIATRYWoS-id: 000632825200001
Scopus-id: 2-s2.0-85099259166
1111
21Exploring the relationship between impaired illness awareness and visuospatial inattention in patients with schizophreniaCoautor: Graff-Guerrero A., Daniell K., Kim J., Iwata Y., et al.2021JOURNAL OF PSYCHIATRIC RESEARCHWoS-id: 000634106600017
Scopus-id: 2-s2.0-85095805374
55
22Metformin for early comorbid glucose dysregulation and schizophrenia spectrum disorders: a pilot double-blind randomized clinical trialCoautor: Graff-Guerrero A., Agarwal S.M., Panda R., Costa-Dookhan K.A., et al.2021TRANSLATIONAL PSYCHIATRYWoS-id: 000640462600002
Scopus-id: 2-s2.0-85104467453
2221
23Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia with Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level DataCoautor: Graff-Guerrero A., Merritt K., McGuire P.K., Egerton A., et al.2021JAMA PSYCHIATRYWoS-id: 000642599600003
Scopus-id: 2-s2.0-85105228782
7576
24Autonomic nervous system dysfunction in schizophrenia: impact on cognitive and metabolic healthCoautor: Graff-Guerrero A., Stogios N., Gdanski A., Gerretsen P., et al.2021Npj SchizophreniaWoS-id: 000644642400001
Scopus-id: 2-s2.0-85113910112
4246
25A measure of illness awareness in alcohol use disorder?Alcohol Use Awareness and Insight Scale (AAS)Coautor: Graff-Guerrero A., Kim J., Taggar A., Quilty L.C., et al.2021DRUG AND ALCOHOL DEPENDENCEWoS-id: 000683571200007
Scopus-id: 2-s2.0-85111477292
67
26Adiposity in schizophrenia: A systematic review and meta-analysisCoautor: Graff-Guerrero A., Smith E., Singh R., Lee J., et al.2021ACTA PSYCHIAT SCANDWoS-id: 000696392600001
Scopus-id: 2-s2.0-85115106904
2021
27Individual determinants of COVID-19 vaccine hesitancyCoautor: Graff-Guerrero A., Gerretsen P., Kim J., Caravaggio F., et al.2021PLOS ONEWoS-id: 000735920500005
Scopus-id: 2-s2.0-85119400535
118125
28Vaccine Hesitancy Is a Barrier to Achieving Equitable Herd Immunity Among Racial MinoritiesCoautor: Graff-Guerrero A., Gerretsen P., Kim J., Quilty L., et al.2021Frontiers In MedicineWoS-id: 000739068600001
Scopus-id: 2-s2.0-85120915659
2424
29Further in vivo characterization of [11C]-(+)-PHNO uptake into a retina-like region of interest in humansCoautor: Graff-Guerrero A., Caravaggio F., Worhunsky P., Matuskey D.2020SynapseWoS-id: 000487992600001
Scopus-id: 2-s2.0-85073938925
11
30Impaired Awareness of Problem and Pathological Gambling: A ReviewCoautor: Graff-Guerrero A., Shah P., Quilty L., Kim J., et al.2020J GAMBL STUDWoS-id: 000503656700001
Scopus-id: 2-s2.0-85077091264
88
31Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy studyCoautor: Graff-Guerrero A., Tarumi R., Tsugawa S., Noda Y., et al.2020NEUROPSYCHOPHARMACOLOGYWoS-id: 000513343000008
Scopus-id: 2-s2.0-85077063248
4848
32Neuroanatomical profiles of treatment-resistance in patients with schizophrenia spectrum disordersCoautor: Graff-Guerrero A., Kim J., Plitman E., Iwata Y., et al.2020PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRYWoS-id: 000518756400026
Scopus-id: 2-s2.0-85076518277
1416
33White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: A diffusion tensor imaging studyCoautor: Graff-Guerrero A., Ochi R., Noda Y., Tsuchimoto S., et al.2020PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRYWoS-id: 000522807700027
Scopus-id: 2-s2.0-85078487007
2024
34DAS: The Diabetes Awareness and Insight ScaleCoautor: Graff-Guerrero A., Kim J., Shah P., Quilty L.C., et al.2020DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWSWoS-id: 000527286500004
Scopus-id: 2-s2.0-85080135939
99
35Glutamatergic neurometabolites and cortical thickness in treatment-resistant schizophrenia: Implications for glutamate-mediated excitotoxicityCoautor: Graff-Guerrero A., Shah P., Plitman E., Iwata Y., et al.2020JOURNAL OF PSYCHIATRIC RESEARCHWoS-id: 000528204800021
Scopus-id: 2-s2.0-85081004876
3130
36Brain insulin action: Implications for the treatment of schizophreniaCoautor: Graff-Guerrero A., Agarwal S.M., Kowalchuk C., Castellani L., et al.2020NeuropharmacologyWoS-id: 000528256100007
Scopus-id: 2-s2.0-85082199656
2322
37Insight and medication adherence in schizophrenia: An analysis of the CATIE trialCoautor: Graff-Guerrero A., Kim J., Ozzoude M., Nakajima S., et al.2020NeuropharmacologyWoS-id: 000528256100016
Scopus-id: 2-s2.0-85067640551
6567
38Design and Rationale of the PACt-MD Randomized Clinical Trial: Prevention of Alzheimer's dementia with Cognitive remediation plus transcranial direct current stimulation in Mild cognitive impairment and DepressionCoautor: Graff-Guerrero A., Rajji T.K., Bowie C.R., Herrmann N., et al.2020JOURNAL OF ALZHEIMERS DISEASEWoS-id: 000551104100028
Scopus-id: 2-s2.0-85088112445
2933
39Apathy is not associated with reduced ventral striatal volume in patients with schizophreniaCoautor: Graff-Guerrero A., Burrer A., Caravaggio F., Manoliu A., et al.2020SCHIZOPHRENIA RESEARCHWoS-id: 000598171600037
Scopus-id: 2-s2.0-85090696217
45
40Exploring patterns of disturbed eating in psychosis: A scoping reviewCoautor: Graff-Guerrero A., Stogios N., Smith E., Asgariroozbehani R., et al.2020NutrientsWoS-id: 000602481000001
Scopus-id: 2-s2.0-85098277594
1916
41The effects of illness severity, cognition, and estimated antipsychotic dopamine receptor occupancy on insight into the illness in schizophrenia: An analysis of clinical antipsychotic trials of intervention effectiveness (CATIE) dataCoautor: Graff-Guerrero A., Ozzoude M., Nakajima S., Plitman E., et al.2019PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRYWoS-id: 000450287400024
Scopus-id: 2-s2.0-85053447457
56
42A meta-analysis of transcranial direct current stimulation for schizophrenia: ?Is more better??Coautor: Graff-Guerrero A., Kim J., Iwata Y., Plitman E., et al.2019JOURNAL OF PSYCHIATRIC RESEARCHWoS-id: 000458711100016
Scopus-id: 2-s2.0-85059550715
4550
43Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy StudyCoautor: Graff-Guerrero A., Iwata Y., Nakajima S., Plitman E., et al.2019BIOLOGICAL PSYCHIATRYWoS-id: 000460728200015
Scopus-id: 2-s2.0-85055756770
9196
44Subiculum volumes associated with memory function in the oldest-old individuals aged 95 years and olderCoautor: Graff-Guerrero A., Eguchi Y., Noda Y., Nakajima S., et al.2019GERIATRICS & GERONTOLOGY INTERNATIONALWoS-id: 000462919800013
Scopus-id: 2-s2.0-85062342204
55
45Neuroimaging correlates of narcolepsy with cataplexy: A systematic reviewCoautor: Graff-Guerrero A., Wada M., Mimura M., Noda Y., et al.2019NEUROSCIENCE RESEARCHWoS-id: 000465164800003
Scopus-id: 2-s2.0-85044525692
2425
46Lead (pb) in alzheimer?s dementia: A systematic review of human case-control studiesCoautor: Graff-Guerrero A., Brown E.E., Shah P., Pollock B.G., et al.2019CURRENT ALZHEIMER RESEARCHWoS-id: 000465506200008
Scopus-id: 2-s2.0-85066397308
1313
47Impaired illness awareness in schizophrenia and posterior corpus callosal white matter tract integrityCoautor: Graff-Guerrero A., Gerretsen P., Rajji T.K., Shah P., et al.2019Npj SchizophreniaWoS-id: 000466155200001
Scopus-id: 2-s2.0-85065062879
1111
48Alterations in body mass index and waist-to-hip ratio in never and minimally treated patients with psychosis: A systematic review and meta-analysisCoautor: Graff-Guerrero A., Shah P., Iwata Y., Caravaggio F., et al.2019SCHIZOPHRENIA RESEARCHWoS-id: 000469022400060
Scopus-id: 2-s2.0-85060293343
2628
49Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studiesCoautor: Graff-Guerrero A., Moriguchi S., Takamiya A., Noda Y., et al.2019MOLECULAR PSYCHIATRYWoS-id: 000472147900002
Scopus-id: 2-s2.0-85054730377
216224
50Brain degeneration in Parkinson?s disease patients with cognitive decline: a coordinate-based meta-analysisCoautor: Graff-Guerrero A., Mihaescu A.S., Masellis M., Kim J., et al.2019BRAIN IMAGING AND BEHAVIORWoS-id: 000475782100014
Scopus-id: 2-s2.0-85049581055
3740
51Acute and long-term effects of electroconvulsive therapy on human dentate gyrusCoautor: Graff-Guerrero A., Takamiya A., Plitman E., Chung J.K., et al.2019NEUROPSYCHOPHARMACOLOGYWoS-id: 000480643900018
Scopus-id: 2-s2.0-85060672841
4948
52Modulation of brain activity with transcranial direct current stimulation: Targeting regions implicated in impaired illness awareness in schizophreniaCoautor: Graff-Guerrero A., Kim J., Plitman E., Nakajima S., et al.2019EUROPEAN PSYCHIATRYWoS-id: 000483706200009
Scopus-id: 2-s2.0-85069205382
1313
53Resting-state functional connectivity in treatment response and resistance in schizophrenia: A systematic reviewCoautor: Graff-Guerrero A., Chan N.K., Kim J., Shah P., et al.2019SCHIZOPHRENIA RESEARCHWoS-id: 000483919600002
Scopus-id: 2-s2.0-85069586599
1617
54Glutathione levels and activities of glutathione metabolism enzymes in patients with schizophrenia: A systematic review and meta-analysisCoautor: Graff-Guerrero A., Tsugawa S., Noda Y., Tarumi R., et al.2019J PSYCHOPHARMACOLWoS-id: 000487975000002
Scopus-id: 2-s2.0-85065421008
4956
55Brain Amyloid PET Tracer Delivery is Related to White Matter Integrity in Patients with Mild Cognitive ImpairmentCoautor: Graff-Guerrero A., Brown E.E., Rashidi-Ranjbar N., Caravaggio F., et al.2019JOURNAL OF NEUROIMAGINGWoS-id: 000492414700006
Scopus-id: 2-s2.0-85068529779
66
56Can we accurately classify schizophrenia patients from healthy controls using magnetic resonance imaging and machine learning? A multi-method and multi-dataset studyCoautor: Graff-Guerrero A., Winterburn J.L., Voineskos A.N., Devenyi G.A., et al.2019SCHIZOPHRENIA RESEARCHWoS-id: 000502568900002
Scopus-id: 2-s2.0-85038881432
4858
57Cross-cultural psychometric assessment of the VAGUS insight into psychosis scale ? Spanish versionCoautor: Graff-Guerrero A., de León P.P., Gerretsen P., Shah P., et al.2018PSYCHIATRY RESEARCHWoS-id: 000423648700070
Scopus-id: 2-s2.0-85035045283
22
58Effect of electroconvulsive therapy on hippocampal and amygdala volumes: Systematic review and meta-analysisCoautor: Graff-Guerrero A., Takamiya A., Chung J.K., Liang K.-C., et al.2018BRIT J PSYCHIATWoS-id: 000424204000008
Scopus-id: 2-s2.0-85043473897
8789
59Prefrontal and Striatal Gamma-Aminobutyric Acid Levels and the Effect of Antipsychotic Treatment in First-Episode Psychosis PatientsCoautor: Graff-Guerrero A., de la Fuente-Sandoval C., Reyes-Madrigal F., Mao X., et al.2018BIOLOGICAL PSYCHIATRYWoS-id: 000424667200005
Scopus-id: 2-s2.0-85033588199
6160
60Amotivation is associated with smaller ventral striatum volumes in older patients with schizophreniaCoautor: Graff-Guerrero A., Caravaggio F., Fervaha G., Iwata Y., et al.2018INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRYWoS-id: 000424820600011
Scopus-id: 2-s2.0-85041728557
99
61Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability studyCoautor: Graff-Guerrero A., Plitman E., Chavez S., Nakajima S., et al.2018PSYCHIATRY RESEARCH-NEUROIMAGINGWoS-id: 000425992100003
Scopus-id: 2-s2.0-85042905959
1313
62Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional StudyCoautor: Graff-Guerrero A., Wada M., Noda Y., Shinagawa S., et al.2018JOURNAL OF ALZHEIMERS DISEASEWoS-id: 000430831000035
Scopus-id: 2-s2.0-85048377952
3439
63Sequential drug treatment algorithm for agitation and aggression in Alzheimer?s and mixed dementiaCoautor: Graff-Guerrero A., Davies S.J.C., Burhan A.M., Kim D., et al.2018J PSYCHOPHARMACOLWoS-id: 000432091100002
Scopus-id: 2-s2.0-85042564036
7789
64Psychiatric benefits of lithium in water supplies may be due to protection from the neurotoxicity of lead exposureCoautor: Graff-Guerrero A., Brown E.E., Gerretsen P., Pollock B.2018MEDICAL HYPOTHESESWoS-id: 000432762500021
Scopus-id: 2-s2.0-85045426202
1819
65Kynurenine pathway in depression: A systematic review and meta-analysisCoautor: Graff-Guerrero A., Ogyu K., Kubo K., Noda Y., et al.2018NEUROSCIENCE AND BIOBEHAVIORAL REVIEWSWoS-id: 000436350200002
Scopus-id: 2-s2.0-85044973217
198212
66Neurometabolite levels in antipsychotic-naïve/free patients with schizophrenia: A systematic review and meta-analysis of 1H-MRS studiesCoautor: Graff-Guerrero A., Iwata Y., Nakajima S., Plitman E., et al.2018PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRYWoS-id: 000436416800039
Scopus-id: 2-s2.0-85049051208
4349
67Structural and functional alterations of the suicidal brain: An updated review of neuroimaging studiesCoautor: Graff-Guerrero A., Bani-Fatemi A., Tasmim S., Gerretsen P., et al.2018PSYCHIATRY RESEARCH-NEUROIMAGINGWoS-id: 000437789300011
Scopus-id: 2-s2.0-85048776343
7282
68The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic reviewCoautor: Graff-Guerrero A., Shah P., Iwata Y., Plitman E., et al.2018PSYCHIATRY RESEARCHWoS-id: 000445990300020
Scopus-id: 2-s2.0-85049774360
6168
69Expression of dopamine D2 and D3 receptors in the human retina revealed by positron emission tomography and targeted mass spectrometryCoautor: Graff-Guerrero A., Caravaggio F., Scifo E., Sibille E.L., et al.2018EXPERIMENTAL EYE RESEARCHWoS-id: 000447574000004
Scopus-id: 2-s2.0-85048592445
2120
70The neural correlates of apathy in schizophrenia: An exploratory investigationCoautor: Graff-Guerrero A., Caravaggio F., Fervaha G., Menon M., et al.2018NeuropsychologiaWoS-id: 000450541000005
Scopus-id: 2-s2.0-85032362968
711
71Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in SchizophreniaCoautor: Graff-Guerrero A., MacKenzie N.E., Kowalchuk C., Agarwal S.M., et al.2018Frontiers in PsychiatryWoS-id: 000452131400001
Scopus-id: 2-s2.0-85065040288
131136
72Trait impulsivity is not related to post-commissural putamen volumes: A replication study in healthy menCoautor: Graff-Guerrero A., Caravaggio F., Plavén-Sigray P., Matheson G.J., et al.2018PLOS ONEWoS-id: 000453841700088
Scopus-id: 2-s2.0-85058776050
55
73Does Family History of Alcohol Use Disorder Relate to Differences in Regional Brain Volumes? A Descriptive Review with New DataCoautor: Graff-Guerrero A., McPhee M.D., Claus E.D., Boileau I., et al.2018ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCHWoS-id: 000456922700009
Scopus-id: 2-s2.0-85055022765
66
74La Deseabilidad Social Como Predictor Lel Trastorno Antisocial Le La Personalidad en ReclusosCoautor y autor de correspondencia: Graff-Guerrero A., Padrós-Blázquez F., Del Carmen Domínguez Espinosa A.2018REVISTA MEXICANA DE PSICOLOGIAScopus-id: 2-s2.0-85067549810
02
75Exploring the relationship between social attachment and dopamine D2/3 receptor availability in the brains of healthy humans using [11C]-(+)-PHNOCoautor: Graff-Guerrero A., Caravaggio F., Chung J.K., Gerretsen P., et al.2017SOCIAL NEUROSCIENCEWoS-id: 000395098000006
Scopus-id: 2-s2.0-84961212212
910
76Cognition and Dopamine D2 Receptor Availability in the Striatum in Older Patients with SchizophreniaCoautor: Graff-Guerrero, A., Rajji, T.K., Mulsant, B.H., Nakajima, S., et al.2017AMERICAN JOURNAL OF GERIATRIC PSYCHIATRYWoS-id: 000396484300001
Scopus-id: 2-s2.0-84994403358
1216
77Treatment-ResistantSchizophrenia: TreatmentResponse and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and TerminologyCoautor: Graff-Guerrero, A., Howes, O.D., McCutcheon, R., Agid, O., et al.2017AM J PSYCHIATWoS-id: 000396664700008
Scopus-id: 2-s2.0-85014440556
708747
78Impaired illness awareness and leftward visuospatial inattention in schizophrenia are attributable to a common neural deficit ? Posterior parietal hemispheric imbalanceCoautor: Graff-Guerrero, A., Kim, J., Plitman, E., Nakajima, S., et al.2017MEDICAL HYPOTHESESWoS-id: 000397074200006
Scopus-id: 2-s2.0-85009926971
11
79Is antipsychotic sensitivity in Alzheimer's disease secondary to abnormal blood-brain barrier integrity?2ᵒ autor y autor de correspondencia: Graff-Guerrero A., Caravaggio F.2017BrainWoS-id: 000397319400011
Scopus-id: 2-s2.0-85028537307
11
80Insight into illness and its relationship to illness severity, cognition and estimated antipsychotic dopamine receptor occupancy in schizophrenia: An antipsychotic dose reduction studyCoautor: Graff-Guerrero, A., Gerretsen, P., Takeuchi, H., Ozzoude, M., et al.2017PSYCHIATRY RESEARCHWoS-id: 000399509400004
Scopus-id: 2-s2.0-85011664895
99
81Vestibular stimulation improves insight into illness in schizophrenia spectrum disordersCoautor: Graff-Guerrero, A., Gerretsen, P., Pothier, D.D., Falls, C., et al.2017PSYCHIATRY RESEARCHWoS-id: 000399509400055
Scopus-id: 2-s2.0-85013857909
78
82Altered functional connectivity in brain networks underlying self-referential processing in delusions of reference in schizophreniaCoautor: Graff-Guerrero, A., Larivière, S., Lavigne, K.M., Woodward, T.S., et al.2017PSYCHIATRY RESEARCH-NEUROIMAGINGWoS-id: 000401878100005
Scopus-id: 2-s2.0-85018400479
3232
83Investigating the effects of norepinephrine a1 receptor blockade on dopamine levels: A pilot PET study with [11C]-(+)-PHNO in controlsCoautor: Graff-Guerrero A., Le Foll B., Thiruchselvam T., Lu S.X., et al.2017SynapseWoS-id: 000402040600002
Scopus-id: 2-s2.0-85017350284
33
84Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease PathologyCoautor: Graff-Guerrero, A., Chung, J.K., Plitman, E., Nakajima, S., et al.2017JOURNAL OF ALZHEIMERS DISEASEWoS-id: 000402995800014
Scopus-id: 2-s2.0-85020378070
910
85Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysisCoautor: Graff-Guerrero, A., Plitman, E., Iwata, Y., Caravaggio, F., et al.2017SCHIZOPHRENIA BULLETINWoS-id: 000403344200015
Scopus-id: 2-s2.0-85021819812
148159
86Intranasal oxytocin does not modulate jumping to conclusions in schizophrenia: Potential interactions with caudate volume and baseline social functioningCoautor: Graff-Guerrero, A., Caravaggio, F., Gerretsen, P., Mar, W., et al.2017PSYCHONEUROENDOCRINOLOGYWoS-id: 000404815200011
Scopus-id: 2-s2.0-85017634882
910
87Insight into illness and cognition in schizophrenia in earlier and later lifeCoautor: Graff-Guerrero, A., Gerretsen, P., Voineskos, A.N., Menon, M., et al.2017JOURNAL OF CLINICAL PSYCHIATRYWoS-id: 000405488000004
Scopus-id: 2-s2.0-85018424436
912
88The relationship between subcortical brain volume and striatal dopamine D2/3 receptor availability in healthy humans assessed with [11C]-raclopride and [11C]-(+)-PHNO PETCoautor: Graff-Guerrero A., Caravaggio F., Ku Chung J., Plitman E., et al.2017HUMAN BRAIN MAPPINGWoS-id: 000412553900013
Scopus-id: 2-s2.0-85026375416
1413
89Psychosocial or clinico-demographic factors related to neuropsychiatric symptoms in patients with Alzheimer's disease needing interventional treatment: analysis of the CATIE-AD studyCoautor: Graff-Guerrero A., Nagata T., Nakajima S., Shinagawa S., et al.2017INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRYWoS-id: 000416425200031
Scopus-id: 2-s2.0-84990946226
2928
90Anosognosia g pIS an independent py g predictor of conversion y From mild cognitive impairment to Alzheimer?s disease and is associated with reduced brain metabolismCoautor: Graff-Guerrero A., Gerretsen P., Chung J.K., Shah P., et al.2017JOURNAL OF CLINICAL PSYCHIATRYWoS-id: 000418792500005
Scopus-id: 2-s2.0-85040071979
3637
91Occupancy of Dopamine D3 and D2 Receptors by Buspirone: A [11C]-(+)-PHNO PET Study in HumansCoautor: Graff-Guerrero A., Le Foll B., Payer D., Di Ciano P., et al.2016NEUROPSYCHOPHARMACOLOGYWoS-id: 000366599400015
Scopus-id: 2-s2.0-84949551585
2323
92The effect of striatal dopamine depletion on striatal and cortical glutamate: A mini-reviewCoautor: Graff-Guerrero A., Caravaggio F., Nakajima S., Plitman E., et al.2016PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRYWoS-id: 000366709200005
Scopus-id: 2-s2.0-84940851206
1821
93Depressive symptoms and small hippocampal volume accelerate the progression to dementia from mild cognitive impairmentCoautor: Graff-Guerrero A., Chung J.K., Plitman E., Nakajima S., et al.2016JOURNAL OF ALZHEIMERS DISEASEWoS-id: 000367104100014
Scopus-id: 2-s2.0-84949972289
3538
94Dopamine D2/3 Receptor Occupancy Following Dose Reduction Is Predictable with Minimal Plasma Antipsychotic Concentrations: An Open-Label Clinical TrialCoautor: Graff-Guerrero A., Nakajima S., Uchida H., Bies R.R., et al.2016SCHIZOPHRENIA BULLETINWoS-id: 000368629000024
Scopus-id: 2-s2.0-84954357476
2125
95The Effect of Task-Irrelevant Fearful-Face Distractor on Working Memory Processing in Mild Cognitive Impairment versus Healthy Controls: An Exploratory fMRI Study in Female ParticipantsCoautor: Graff-Guerrero A., Burhan A.M., Anazodo U.C., Chung J.K., et al.2016BEHAVIOURAL NEUROLOGYWoS-id: 000370268700001
Scopus-id: 2-s2.0-84959019070
78
96Exploring personality traits related to dopamine D2/3 receptor availability in striatal subregions of humansCoautor: Graff-Guerrero A., Caravaggio F., Fervaha G., Chung J.K., et al.2016EUROPEAN NEUROPSYCHOPHARMACOLOGYWoS-id: 000372546300002
Scopus-id: 2-s2.0-84960830508
2223
97Elevated myo-inositol, choline, and glutamate levels in the associative striatum of antipsychotic-naive patients with first-episode psychosis: A proton magnetic resonance spectroscopy study with implications for glial dysfunctionCoautor: Graff-Guerrero A., Plitman E., De Fuente-Sandoval C.L., Reyes-Madrigal F., et al.2016SCHIZOPHRENIA BULLETINWoS-id: 000376401500020
Scopus-id: 2-s2.0-84964906124
7679
98GWAS analysis of suicide attempt in schizophrenia: Main genetic effect and interaction with early life trauma2ᵒ autor: Graff, A., Bani-Fatemi, A., Zai, C., Strauss, J., et al.2016NEUROSCIENCE LETTERSWoS-id: 000376834300019
Scopus-id: 2-s2.0-84973131423
1921
99Switching From 2 antipsychotics to 1 Antipsychotic in schizophrenia: A randomized, double-blind, placebo-controlled studyCoautor: Graff-Guerrero A., Borlido C., Remington G., Arenovich T., et al.2016JOURNAL OF CLINICAL PSYCHIATRYWoS-id: 000379250300003
Scopus-id: 2-s2.0-84957831595
1822
100Glutamatergic metabolites, volume and cortical thickness in antipsychotic-naive patients with first-episode psychosis: Implications for excitotoxicityCoautor: Graff-Guerrero, A., Plitman, E., Patel, R., Chung, J.K., et al.2016NEUROPSYCHOPHARMACOLOGYWoS-id: 000381653400019
Scopus-id: 2-s2.0-84976443466
4647
101Estimating the effect of endogenous dopamine on baseline [11C]-(+)-PHNO binding in the human brainCoautor: Graff-Guerrero, A., Caravaggio, F., Kegeles, L.S., Wilson, A.A., et al.2016SynapseWoS-id: 000383714000002
Scopus-id: 2-s2.0-84991726447
1514
102Tau in Late-Life Depression: A Systematic Review and Meta-AnalysisCoautor: Graff-Guerrero, A., Brown, E.E., Iwata, Y., Chung, J.K., et al.2016JOURNAL OF ALZHEIMERS DISEASEWoS-id: 000384087200017
Scopus-id: 2-s2.0-84986550165
2121
103Erratum: Corrigendum to ?abnormal white matter integrity in antipsychotic-naïve first-episode psychosis patients assessed by a DTI principal component analysis? (Schizophr. Res. (2015) 162(1?3) (14?21)(S0920996415000237)(10.1016/j.schres.2015.01.019))Coautor: Graff-Guerrero, A., Alvarado-Alanis, P., León-Ortiz, P., Reyes-Madrigal, F., et al.2016SCHIZOPHRENIA RESEARCHWoS-id: 000384130200081
Scopus-id: 2-s2.0-84976564695
11
104Lack of association between dopaminergic antagonism and negative symptoms in schizophrenia: a positron emission tomography dopamine D2/3 receptor occupancy studyCoautor: Graff-Guerrero, A., Fervaha, G., Caravaggio, F., Mamo, D.C., et al.2016PsychopharmacologyWoS-id: 000385518500013
Scopus-id: 2-s2.0-84983457791
1012
105?-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia: A Systematic ReviewCoautor: Graff-Guerrero, A., Chung, J.K., Nakajima, S., Plitman, E., et al.2016AMERICAN JOURNAL OF GERIATRIC PSYCHIATRYWoS-id: 000386770900023
Scopus-id: 2-s2.0-84994908881
1617
106Benzodiazepine Use Attenuates Cortical ?-Amyloid and is Not Associated with Progressive Cognitive Decline in Nondemented Elderly Adults: A Pilot Study Using F18-Florbetapir Positron Emission TomographyCoautor: Graff-Guerrero, A., Chung, J.K., Nakajima, S., Shinagawa, S., et al.2016AMERICAN JOURNAL OF GERIATRIC PSYCHIATRYWoS-id: 000386771200013
Scopus-id: 2-s2.0-84992209043
2020
107The efficacy of non-pharmacological interventions on brain-derived neurotrophic factor in schizophrenia: A systematic review and meta-analysisCoautor: Graff-Guerrero, A., Sanada, K., Zorrilla, I., Iwata, Y., et al.2016INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESWoS-id: 000387768300003
Scopus-id: 2-s2.0-84992743699
2930
108Threshold of dopamine D2/3 receptor occupancy for hyperprolactinemia in older patients with schizophreniaCoautor: Graff-Guerrero, A., Iwata, Y., Nakajima, S., Caravaggio, F., et al.2016JOURNAL OF CLINICAL PSYCHIATRYWoS-id: 000393022700002
Scopus-id: 2-s2.0-85007608229
911
109Illness denial in schizophrenia spectrum disorders: A function of left hemisphere dominanceCoautor: Graff-Guerrero A., Gerretsen P., Menon M., Chakravarty M.M., et al.2015HUMAN BRAIN MAPPINGWoS-id: 000346190800016
Scopus-id: 2-s2.0-84916641164
3233
110Ventral striatum binding of a dopamine D2/3 receptor agonist but not antagonist predicts normal body mass indexCoautor: Graff-Guerrero A., Caravaggio F., Raitsin S., Gerretsen P., et al.2015BIOLOGICAL PSYCHIATRYWoS-id: 000346386600015
Scopus-id: 2-s2.0-84918769636
4447
111Extrapyramidal symptoms and cognitive test performance in patients with schizophreniaCoautor: Graff-Guerrero A., Fervaha G., Agid O., Takeuchi H., et al.2015SCHIZOPHRENIA RESEARCHWoS-id: 000348452100030
Scopus-id: 2-s2.0-84921455993
3333
112Comparative efficacy between clozapine and other atypical antipsychotics on depressive symptoms in patients with schizophrenia: Analysis of the CATIE phase 2E dataCoautor: Graff-Guerrero A., Nakajima S., Takeuchi H., Fervaha G., et al.2015SCHIZOPHRENIA RESEARCHWoS-id: 000348452100042
Scopus-id: 2-s2.0-84921489342
2226
113Dose-dependent effects of intravenous alcohol administration on cerebral blood flow in young adultsCoautor: Graff-Guerrero A., Strang N.M., Claus E.D., Ramchandani V.A., et al.2015PsychopharmacologyWoS-id: 000348982800007
Scopus-id: 2-s2.0-84930748109
2935
114Abnormal white matter integrity in antipsychotic-naïve first-episode psychosis patients assessed by a DTI principal component analysisCoautor: Graff-Guerrero A., Alvarado-Alanis P., León-Ortiz P., Reyes-Madrigal F., et al.2015SCHIZOPHRENIA RESEARCHWoS-id: 000349966400003
Scopus-id: 2-s2.0-84923230373
3033
115Imaging-based neurochemistry in schizophrenia: a systematic review and implications for dysfunctional long-term potentiationCoautor: Graff-Guerrero, A., Salavati, B., Rajji, T.K., Price, R., et al.2015SCHIZOPHRENIA BULLETINWoS-id: 000350057900013
Scopus-id: 2-s2.0-84979850412
5860
116Non-pharmacological management for patients with frontotemporal dementia: A systematic reviewCoautor: Graff-Guerrero A., Shinagawa S., Nakajima S., Plitman E., et al.2015JOURNAL OF ALZHEIMERS DISEASEWoS-id: 000350573800025
Scopus-id: 2-s2.0-84924120506
2530
117Lifetime History of Depression Predicts Increased Amyloid-ß Accumulation in Patients with Mild Cognitive ImpairmentCoautor: Graff-Guerrero A., Chung J.K., Plitman E., Nakajima S., et al.2015JOURNAL OF ALZHEIMERS DISEASEWoS-id: 000351608700020
Scopus-id: 2-s2.0-84925725593
5351
118Neuroimaging findings in treatment-resistant schizophrenia: A systematic review: Lack of neuroimaging correlates of treatment-resistant schizophreniaCoautor: Graff-Guerrero A., Nakajima S., Takeuchi H., Plitman E., et al.2015SCHIZOPHRENIA RESEARCHWoS-id: 000353337100024
Scopus-id: 2-s2.0-84929281198
7074
119Dopamine D2/3 receptor availability in the striatum of antipsychotic-free older patients with schizophrenia-A [11C]-raclopride PET studyCoautor: Graff-Guerrero A., Nakajima S., Caravaggio F., Mamo D.C., et al.2015SCHIZOPHRENIA RESEARCHWoS-id: 000353337100039
Scopus-id: 2-s2.0-84929275413
1015
120Reduced insulin sensitivity is related to less endogenous dopamine at D2/3 receptors in the ventral striatum of healthy nonobese humansCoautor: Graff-Guerrero A., Caravaggio F., Borlido C., Hahn M., et al.2015INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGYWoS-id: 000356702800014
Scopus-id: 2-s2.0-84939190407
5557
121Evaluation of antipsychotic dose reduction in late-life schizophrenia: A prospective dopamine D2/3 receptor occupancy study1ᵉʳ autor: Graff-Guerrero A., Rajji T.K., Mulsant B.H., Nakajima S., et al.2015JAMA PSYCHIATRYWoS-id: 000360987600012
Scopus-id: 2-s2.0-84940974184
6879
122Examining endogenous dopamine in treated schizophrenia using [11C]-(+)-PHNO positron emission tomography: A pilot studyCoautor: Graff-Guerrero A., Caravaggio F., Borlido C., Wilson A.2015CLINICA CHIMICA ACTAWoS-id: 000361580700010
Scopus-id: 2-s2.0-84940440791
2524
123Reduced insulin-receptor mediated modulation of striatal dopamine release by basal insulin as a possible contributing factor to hyperdopaminergia in schizophreniaCoautor: Graff-Guerrero A., Caravaggio F., Hahn M., Nakajima S., et al.2015MEDICAL HYPOTHESESWoS-id: 000361860800002
Scopus-id: 2-s2.0-84942500513
1212
124Effects of glutamate positive modulators on cognitive deficits in schizophrenia: A systematic review and meta-Analysis of double-blind randomized controlled trialsCoautor: Graff-Guerrero A., Iwata Y., Nakajima S., Suzuki T., et al.2015MOLECULAR PSYCHIATRYWoS-id: 000361909800002
Scopus-id: 2-s2.0-84942550270
7884
125Lack of age-dependent decrease in dopamine D 3 receptor availability: A [11C]-(+)-PHNO and [11C]-raclopride positron emission tomography studyCoautor: Graff-Guerrero A., Nakajima S., Caravaggio F., Boileau I., et al.2015JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISMWoS-id: 000364259900013
Scopus-id: 2-s2.0-84946499148
2122
126Predicting Plasma Olanzapine Concentration Following a Change in Dosage: A Population Pharmacokinetic StudyCoautor: Graff-Guerrero A., Tsuboi T., Bies R.R., Suzuki T., et al.2015PharmacopsychiatryWoS-id: 000365531200007
Scopus-id: 2-s2.0-84948105798
56
127Erratum: Lifetime history of depression predicts increased amyloid-ß accumulation in patients with mild cognitive impairment (Journal of Alzheimer's Disease (2015) 45: 3 (907-919)) DOI: 10.3233/JAD-142931)Coautor: Graff-Guerrero A., Chung J.K., Plitman E., Nakajima S., et al.2015JOURNAL OF ALZHEIMERS DISEASEWoS-id: 000367522800026
Scopus-id: 2-s2.0-84953736260
42
128Cortical Amyloid ß Deposition and Current Depressive Symptoms in Alzheimer Disease and Mild Cognitive ImpairmentCoautor: Graff-Guerrero, A., Chung, J.K., Plitman, E., Nakajima, S., et al.2015J GERIATR PSYCH NEURWoS-id: 000373950600006
Scopus-id: 2-s2.0-84962877685
3838
129Cortico-striatal GABAergic and glutamatergic dysregulations in subjects at ultra-high risk for psychosis investigated with proton magnetic resonance spectroscopyCoautor: Graff-Guerrero A., De La Fuente-Sandoval C., Reyes-Madrigal F., Mao X., et al.2015INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGYWoS-id: 000377108200009
Scopus-id: 2-s2.0-84963966449
5912
130Amotivation as central to negative schizotypy and their predictive value for happinessCoautor: Graff-Guerrero A., Fervaha G., Zakzanis K.K., Jeffay E., et al.2014PERSONALITY AND INDIVIDUAL DIFFERENCESWoS-id: 000338688200008
Scopus-id: 2-s2.0-84899827532
1212
131Effects of antipsychotic D2 antagonists on long-term potentiation in animals and implications for human studiesCoautor: Graff-Guerrero A., Price R., Salavati B., Blumberger D.M., et al.2014PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRYWoS-id: 000341167800011
Scopus-id: 2-s2.0-84902464360
1516
132Psychosis in frontotemporal dementiaCoautor: Graff-Guerrero A., Shinagawa S., Nakajima S., Plitman E., et al.2014JOURNAL OF ALZHEIMERS DISEASEWoS-id: 000341572000013
Scopus-id: 2-s2.0-84916879294
5969
133Motivational deficits and cognitive test performance in schizophreniaCoautor: Graff-Guerrero A., Fervaha G., Zakzanis K.K., Foussias G., et al.2014JAMA PSYCHIATRYWoS-id: 000341775300012
Scopus-id: 2-s2.0-84907009282
113119
134Therapeutic window for striatal dopamine D2/3 receptor occupancy in older patients with schizophrenia: A pilot PET studyCoautor: Graff-Guerrero A., Uchida H., Suzuki T., Mulsant B.H., et al.2014AMERICAN JOURNAL OF GERIATRIC PSYCHIATRYWoS-id: 000341934600008
Scopus-id: 2-s2.0-84925245498
2427
135Estimating endogenous dopamine levels at D 2 and D 3 receptors in humans using the agonist radiotracer 11 C-(+)-PHNOCoautor: Graff-Guerrero A., Caravaggio F., Nakajima S., Borlido C., et al.2014NEUROPSYCHOPHARMACOLOGYWoS-id: 000343682500007
Scopus-id: 2-s2.0-84936764958
2929
136The effects of aging on insight into illness in schizophrenia: A reviewCoautor: Graff-Guerrero A., Gerretsen P., Plitman E., Rajji T.K.2014INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRYWoS-id: 000343825900007
Scopus-id: 2-s2.0-84907907377
5862
137Glutamate-mediated excitotoxicity in schizophrenia: A reviewCoautor: Graff-Guerrero, A, Plitman, E, Nakajima, S, de la Fuente-Sandoval, C, et al.2014EUROPEAN NEUROPSYCHOPHARMACOLOGYWoS-id: 000344210800003
Scopus-id: 2-s2.0-84907983364
113123
138Impaired insight into illness and cognitive insight in schizophrenia spectrum disorders: Resting state functional connectivityCoautor: Graff-Guerrero A., Gerretsen P., Menon M., Mamo D.C., et al.2014SCHIZOPHRENIA RESEARCHWoS-id: 000345961300025
Scopus-id: 2-s2.0-84928226884
6263
139Recent methods for measuring dopamine D3 receptor occupancy in vivo: Importance for drug developmentCoautor: Graff A., Le Foll B., Wilson A.A., Boileau I., et al.2014FRONTIERS IN PHARMACOLOGYWoS-id: 000347102900001
Scopus-id: 2-s2.0-84904750865
3939
140The VAGUS insight into psychosis scale - Self-report and clinician-rated versionsCoautor: Graff-Guerrero A., Gerretsen P., Remington G., Borlido C., et al.2014PSYCHIATRY RESEARCHWoS-id: 000347361300052
Scopus-id: 2-s2.0-84919627569
4344
141Predicting dopamine D2 receptor occupancy following antipsychotic dose reduction: A pilot PET studyCoautor: Graff-Guerrero A., Uchida H., Bies R.R., Suzuki T., et al.2014Japanese Journal of PsychopharmacologyScopus-id: 2-s2.0-84901191586
00
142Gaudiebility group therapy in depressed patients: A pilot studyCoautor y autor de correspondencia: Guerrero A.G., Blázquez F.P., Medina P.M.2014International Journal Of Psychology And Psychological TherapyScopus-id: 2-s2.0-84894037655
07
143Glutamate-mediated excitotoxicity in schizophrenia: A reviewCoautor: Graff-Guerrero A., Plitman E., Nakajima S., de la Fuente-Sandoval C., et al.2014EUROPEAN NEUROPSYCHOPHARMACOLOGYScopus-id: 2-s2.0-84906146199
02
144Predicting dopamine D2 receptor occupancy following antipsychotic dose reduction: a pilot PET study.Coautor: Graff-Guerrero A., Uchida H., Bies R.R., Suzuki T., et al.2014Japanese Journal of PsychopharmacologyScopus-id: 2-s2.0-84906921855
00
145Semantic crossover based on the partial derivative error2ᵒ autor: Graff-Guerrero A., Graff M., Cerda-Jacobo J.2014Lecture Notes in Computer ScienceScopus-id: 2-s2.0-84927626277
06
146Fluorodeoxyglucose positron emission tomography in semantic dementia after 6 months of memantine: An open-label pilot studyCoautor: Graff-Guerrero A., Chow T.W., Fam D., Verhoeff N.P.G., et al.2013INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRYWoS-id: 000314751800014
Scopus-id: 2-s2.0-84873567538
512
147Striatal glutamate and the conversion to psychosis: a prospective H-1-MRS imaging studyCoautor: Graff-Guerrero A., De La Fuente-Sandoval C., León-Ortiz P., Azcárraga M., et al.2013INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGYWoS-id: 000314996100020
Scopus-id: 2-s2.0-84875956590
7175
148Frontotemporoparietal asymmetry and lack of illness awareness in schizophreniaCoautor: Graff-Guerrero A., Gerretsen P., Chakravarty M.M., Mamo D., et al.2013HUMAN BRAIN MAPPINGWoS-id: 000317297500004
Scopus-id: 2-s2.0-84875899642
3938
149A case of apathy due to frontotemporal dementia responsive to memantineCoautor: Graff-Guerrero A., Links K.A., Black S.E., Wilson A.A., et al.2013NeurocaseWoS-id: 000320357100004
Scopus-id: 2-s2.0-84879515368
66
150Dopamine D2/3 occupancy of ziprasidone across a day: A within-subject PET study2ᵒ autor: Graff-Guerrero A., Suzuki T., Uchida H., Remington G., et al.2013PsychopharmacologyWoS-id: 000320365100004
Scopus-id: 2-s2.0-84879247453
1617
151Hyperprolactinemia and estimated dopamine D2 receptor occupancy in patients with schizophrenia: Analysis of the CATIE dataCoautor: Graff-Guerrero A., Tsuboi T., Bies R.R., Suzuki T., et al.2013PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRYWoS-id: 000323238300024
Scopus-id: 2-s2.0-84879330939
2732
152Effects of risperidone and olanzapine dose reduction on cognitive function in stable patients with schizophrenia: An open-label, randomized, controlled, pilot studyCoautor: Graff-Guerrero A., Takeuchi H., Suzuki T., Remington G., et al.2013SCHIZOPHRENIA BULLETINWoS-id: 000323972700011
Scopus-id: 2-s2.0-84883476426
9095
153Insight into illness in late-life schizophrenia: A function of illness severity and premorbid intellectual functionCoautor: Graff-Guerrero A., Gerretsen P., Mulsant B.H., Liu A.Y., et al.2013SCHIZOPHRENIA RESEARCHWoS-id: 000324294700036
Scopus-id: 2-s2.0-84884148004
1211
154The potential role of dopamine D3 receptor neurotransmission in cognitionCoautor: Graff-Guerrero A., Nakajima S., Gerretsen P., Takeuchi H., et al.2013EUROPEAN NEUROPSYCHOPHARMACOLOGYWoS-id: 000324602700008
Scopus-id: 2-s2.0-84881664162
148154
155Glutamate Levels in the Associative Striatum Before and After 4 Weeks of Antipsychotic Treatment in First-Episode Psychosis A Longitudinal Proton Magnetic Resonance Spectroscopy StudyCoautor: Graff-Guerrero A., De La Fuente-Sandoval C., León-Ortiz P., Azcárraga M., et al.2013JAMA PSYCHIATRYWoS-id: 000325184100010
Scopus-id: 2-s2.0-84885218013
153159
156Incentive motivation deficits in schizophrenia reflect effort computation impairments during cost-benefit decision-making2ᵒ autor: Graff-Guerrero A., Fervaha G., Zakzanis K.K., Foussias G., et al.2013JOURNAL OF PSYCHIATRIC RESEARCHWoS-id: 000325841600006
Scopus-id: 2-s2.0-84884416870
172173
157Neural response to experimental heat pain in stable patients with schizophreniaCoautor: Graff-Guerrero A., de la Fuente-Sandoval C., Favila R., Gómez-Martín D., et al.2012JOURNAL OF PSYCHIATRIC RESEARCHWoS-id: 000298527900017
Scopus-id: 2-s2.0-81855175369
1720
158Reply to 'Letter in reference to de la Fuente-Sandoval, C et al. Neuropsychopharmacology 36, 1781-1791, 2011'2ᵒ autor y autor de correspondencia: Graff-Guerrero A., De La Fuente-Sandoval C.2012NEUROPSYCHOPHARMACOLOGYWoS-id: 000300580100023
Scopus-id: 2-s2.0-84856860442
00
159Development of new carbon-11 labelled radiotracers for imaging GABA A- and GABA B-benzodiazepine receptorsCoautor: Graff A., Moran M.D., Wilson A.A., Elmore C.S., et al.2012BIOORGANIC & MEDICINAL CHEMISTRYWoS-id: 000305952500035
Scopus-id: 2-s2.0-84863211347
2324
160Defining treatment-resistant schizophrenia and response to antipsychotics: A review and recommendationCoautor: Graff-Guerrero A., Suzuki T., Remington G., Mulsant B.H., et al.2012PSYCHIATRY RESEARCHWoS-id: 000306541400001
Scopus-id: 2-s2.0-84862828607
138150
161Therapeutic window for striatal dopamine D2/3 receptor occupancy in older patients with schizophrenia: A pilot PET studyCoautor: Graff-Guerrero A., Uchida H., Suzuki T., Mulsant B.H., et al.2012AMERICAN JOURNAL OF GERIATRIC PSYCHIATRYScopus-id: 2-s2.0-84868250819
01
162Predicting dopamine D2 receptor occupancy from plasma levels of antipsychotic drugs: A systematic review and pooled analysisCoautor: Graff-Guerrero A., Uchida H., Takeuchi H., Suzuki T., et al.2011J CLIN PSYCHOPHARMWoS-id: 000290033100009
Scopus-id: 2-s2.0-79955640309
6780
163Dopamine D2 receptor occupancy and clinical effects: A systematic review and pooled analysisCoautor: Graff-Guerrero A., Uchida H., Takeuchi H., Suzuki T., et al.2011J CLIN PSYCHOPHARMWoS-id: 000292284600014
Scopus-id: 2-s2.0-79960616055
113122
164Higher Levels of Glutamate in the Associative-Striatum of Subjects with Prodromal Symptoms of Schizophrenia and Patients with First-Episode PsychosisCoautor: Graff-Guerrero A., de la Fuente-Sandoval, C, León-Ortiz P., Favila R., et al.2011NEUROPSYCHOPHARMACOLOGYWoS-id: 000292815400002
Scopus-id: 2-s2.0-79960306528
186193
165Transient insight induction with electroconvulsive therapy in a patient with refractory schizophrenia: A case report and systematic literature reviewCoautor: Graff-Guerrero A., Gerretsen P., Diaz P., Mamo D., et al.2011JOURNAL OF ECTWoS-id: 000294250500019
Scopus-id: 2-s2.0-80052446035
76
166Time course of improvement with antipsychotic medication in treatment-resistant schizophreniaCoautor: Graff-Guerrero A., Suzuki T., Remington G., Arenovich T., et al.2011BRIT J PSYCHIATWoS-id: 000295900900005
Scopus-id: 2-s2.0-80053432987
3233
167Effects of aging on 5-HT 2AR binding: A HRRT PET study with and without partial volume correctionsCoautor: Graff-Guerrero A., Uchida H., Chow T.W., Mamo D.C., et al.2011INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRYWoS-id: 000297747800012
Scopus-id: 2-s2.0-80855144203
2021
168Exploring the neural correlates of delusions of referenceCoautor: Graff A., Menon M., Schmitz T.W., Anderson A.K., et al.2011BIOLOGICAL PSYCHIATRYWoS-id: 000297980000007
Scopus-id: 2-s2.0-81855221693
5858
169Treatment resistant schizophrenia and response to antipsychotics: A reviewCoautor: Graff-Guerrero A., Suzuki T., Remington G., Mulsant B.H., et al.2011SCHIZOPHRENIA RESEARCHWoS-id: 000298512500010
Scopus-id: 2-s2.0-81955161935
8697
170Management of schizophrenia in late life with antipsychotic medications: A qualitative reviewCoautor: Graff-Guerrero A., Suzuki T., Remington G., Uchida H., et al.2011DRUG AGINGScopus-id: 2-s2.0-82455175542
023
171Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia2ᵒ autor: Graff-Guerrero A., Chow T.W., Verhoeff N.P.L.G., Binns M.A., et al.2011NEUROPSYCH DIS TREATScopus-id: 2-s2.0-80053647840
023
172Blockade of [C-11](+)-PHNO binding in human subjects by the dopamine D-3 receptor antagonist ABT-9251ᵉʳ autor: Graff-Guerrero, A, Redden, L, Abi-Saab, W, Katz, DA, et al.2010INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGYWoS-id: 000276928200001
Scopus-id: 2-s2.0-77953516008
6362
173The antipsychotics olanzapine, risperidone, clozapine, and haloperidol are d2-selective ex vivo but not in vitroCoautor: Graff-Guerrero A., McCormick P.N., Kapur S., Raymond R., et al.2010NEUROPSYCHOPHARMACOLOGYWoS-id: 000278730300022
Scopus-id: 2-s2.0-77953610258
5660
174Is desire for social relationships mediated by the serotonergic system in the prefrontal cortex? An [18F]setoperone pet study2ᵒ autor: Graff-Guerrero A., Gerretsen P., Menon M., Pollock B.G., et al.2010SOCIAL NEUROSCIENCEWoS-id: 000279966400004
Scopus-id: 2-s2.0-77954566399
2021
175Functional magnetic resonance imaging response to experimental pain in drug-free patients with schizophreniaCoautor: Graff-Guerrero A., de la Fuente-Sandoval C., Favila R., Gómez-Martin D., et al.2010PSYCHIATRY RESEARCH-NEUROIMAGINGWoS-id: 000280946700002
Scopus-id: 2-s2.0-77955054370
3236
176The Dopamine D-2 Receptors in High-Affinity State and D-3 Receptors in Schizophrenia: A Clinical [C-11]-(+)-PHNO PET Study1ᵉʳ autor: Graff-Guerrero A., Mizrahi R., Agid O., Marcon H., et al.2009NEUROPSYCHOPHARMACOLOGYWoS-id: 000263259500024
Scopus-id: 2-s2.0-59949098994
8497
177GLUTAMATE INCREASE IN THE ASSOCIATIVE STRIATUM OF PATIENTS WITH SCHIZOPHRENIA: A HIGH-FIELD PROTON MAGNETIC RESONANCE SPECTROSCOPY LONGITUDINAL STUDYCoautor: Graff-Guerrero, A, de la Fuente-Sandoval, C, Favila, R, Alvarado, P, et al.2009SCHIZOPHRENIA BULLETINWoS-id: 000263964700456
00
178Antipsychotic Dose Reduction and Dopamine D2 receptor Occupancy in Late-Life Schizophrenia: A PET StudyCoautor: Graff-Guerrero, A, Uchida, H, Kapur, S, Mulsant, BH, et al.2009BIOLOGICAL PSYCHIATRYWoS-id: 000265144200664
00
179Sensitivity of older patients to antipsychotic motor side effects: A PET study examining potential mechanismsCoautor: Graff-Guerrero A., Uchida H., Kapur S., Mulsant B.H., et al.2009AMERICAN JOURNAL OF GERIATRIC PSYCHIATRYWoS-id: 000265148300010
Scopus-id: 2-s2.0-67649283706
5261
180Long-term stability of measuring D-2 receptors in schizophrenia patients treated with antipsychotics2ᵒ autor: Graff-Guerrero A., Uchida H., Mulsant B.H., Pollock B.G., et al.2009SCHIZOPHRENIA RESEARCHWoS-id: 000265516300019
Scopus-id: 2-s2.0-62949142048
1114
181The Effect of Antipsychotics on the High-Affinity State of D(2) and D(3) Receptors A Positron Emission Tomography Study With [(11)C]-(+)-PHNO1ᵉʳ autor: Graff-Guerrero A., Mamo D., Shammi C.M., Mizrahi R., et al.2009ARCH GEN PSYCHIATWoS-id: 000266566800005
Scopus-id: 2-s2.0-66449106317
8893
182Glutamate increase in the associative striatum in schizophrenia: a longitudinal magnetic resonance spectroscopy preliminary study.Coautor: Graff-Guerrero, A, de la Fuente-Sandoval, C, Favila, R, Alvarado, P, et al.2009GACETA MEDICA DE MEXICOWoS-id: 000266580100006
Scopus-id: 2-s2.0-67449118800
1515
183The relationship between subjective well-being and dopamine D2 receptors in patients treated with a dopamine partial agonist and full antagonist antipsychoticsCoautor: Graff A., Mizrahi R., Mamo D., Rusjan P., et al.2009INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGYWoS-id: 000266753200013
Scopus-id: 2-s2.0-69749124350
4954
184D-2 Receptor Blockade by Attention Deficits in Risperidone Correlates With Late-Life SchizophreniaCoautor: Graff-Guerrero A., Uchida H., Rajji T.K., Mulsant B.H., et al.2009J CLIN PSYCHOPHARMWoS-id: 000272004300010
Scopus-id: 2-s2.0-72949100183
3944
185Test-retest variability of high resolution positron emission tomography (PET) imaging of cortical serotonin (5HT2A) receptors in older, healthy adultsCoautor: Graff-Guerrero A., Chow T.W., Mamo D.C., Uchida H., et al.2009BMC MEDICAL IMAGINGScopus-id: 2-s2.0-68949211240
012
186First human evidence of d-amphetamine induced displacement of a D-2/3 agonist radioligand: A [C-11]-(+)-PHNO positron emission tomography studyCoautor: Graff A., Willeit M., Ginovart N., Rusjan P., et al.2008NEUROPSYCHOPHARMACOLOGYWoS-id: 000251538100008
Scopus-id: 2-s2.0-36949036673
94102
187Pain perception in schizophrenia: An fMRI longitudinal studyCoautor: Graff-Guerrero, A, De la Fuente-Sandoval, C, Favila, R, Gomez-Martin, D, et al.2008BIOLOGICAL PSYCHIATRYWoS-id: 000254163700802
00
188Cerebral blood flow changes associated with experimental pain stimulation in patients with major depression1ᵉʳ autor: Graff-Guerrero A., Pellicer F., Mendoza-Espinosa Y., Martínez-Medina P., et al.2008JOURNAL OF AFFECTIVE DISORDERSWoS-id: 000254546000018
Scopus-id: 2-s2.0-39649092956
3235
189Brain region binding of the D-2/3 agonist [C-11]-(+)-PHNO and the D-2/3 antagonist [C-11]raclopride in healthy humans1ᵉʳ autor: Graff-Guerrero, A, Willeit, M, Ginovart, N, Mamo, D, et al.2008HUMAN BRAIN MAPPINGWoS-id: 000254799400003
Scopus-id: 2-s2.0-42049106825
9196
190Glutamate quantification in the associative striatum of patients with schizophrenia before and after antipsychotic treatment: a high-field Proton Magnetic Resonance SpectroscopyCoautor: Graff-Guerrero, A, de La Fuente-Sandoval, C, Alvarado, P, Favila-Humara, R, et al.2008INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGYWoS-id: 000258855501311
00
191Positron emission tomography quantification of [11C]-(+)-PHNO binding in the human brainCoautor: Graff A., Ginovart N., Willeit M., Rusjan P., et al.2007JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISMWoS-id: 000245358800021
Scopus-id: 2-s2.0-33947537467
8585
192Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: A PET study in schizophreniaCoautor: Graff A., Mizrahi R., Rusjan P., Agid O., et al.2007AM J PSYCHIATWoS-id: 000245402600018
Scopus-id: 2-s2.0-34247533866
133148
193Differential effects of aripiprazole on D2, 5-HT2, and 5-HT1A receptor occupancy in patients with schizophrenia: A triple tracer PET study2ᵒ autor: Graff A., Mamo D., Mizrahi R., Shammi C.M., et al.2007AM J PSYCHIATWoS-id: 000249266600021
Scopus-id: 2-s2.0-34648830603
192224
194Temporal Difference Modeling of the Blood-Oxygen Level Dependent Response During Aversive Conditioning in Humans: Effects of Dopaminergic ModulationCoautor: Graff-Guerrero A., Menon M., Jensen J., Vitcu I., et al.2007BIOLOGICAL PSYCHIATRYWoS-id: 000249511500008
Scopus-id: 2-s2.0-34548542836
96102
195Cerebral blood flow associated with creative performance: A comparative study2ᵒ autor: Graff-Guerrero A., Chávez-Eakle R.A., García-Reyna J.-C., Vaugier V., et al.2007NeuroimageWoS-id: 000250432200012
Scopus-id: 2-s2.0-35148846040
116138
196The P50 auditory evoked potential in violent and non-violent patients with schizophreniaCoautor: Graff-Guerrero A., Fresán A., Apiquian R., García-Anaya M., et al.2007SCHIZOPHRENIA RESEARCHWoS-id: 000251742000016
Scopus-id: 2-s2.0-36049045735
1322
197Computerized administration of the symptom check list 90 and the Temperament and Character Inventory (TCI) [Versión computarizada para la aplicación del listado de síntomas 90 (SCL 90) Y del Inventario de Temperamento y Carácter (ITC)]Coautor: Graff A., González-Santos L., Mercadillo R.E., Barrios F.A.2007SALUD MENTALScopus-id: 2-s2.0-34548782187
016
198Frontal and limbic metabolic differences in subjects selected according to genetic variation of the SLC6A4 gene polymorphism1ᵉʳ autor: Graff-Guerrero A., De La Fuente-Sandoval C., Camarena B., Gómez-Martin D., et al.2005NeuroimageWoS-id: 000229011200017
Scopus-id: 2-s2.0-20944440085
3541
199Repetitive transcranial magnetic stimulation of dorsolateral prefrontal cortex increases tolerance to human experimental pain1ᵉʳ autor: Graff-Guerrero A., González-Olvera J., Fresán A., Gómez-Martín D., et al.2005COGNITIVE BRAIN RESWoS-id: 000232709600014
Scopus-id: 2-s2.0-24644481457
119139
200rTMS reduces focal brain hyperperfusion in two patients with EPC1ᵉʳ autor: Graff-Guerrero A., Olvera J., Ruiz-García M., Avila-Ordoñez U., et al.2004ACTA NEUROLOGICA SCANDINAVICAWoS-id: 000220154400010
Scopus-id: 2-s2.0-1642443210
3642
201Correlation between cerebral blood flow and items of the Hamilton Rating Scale for Depression in antidepressant-naive patients1ᵉʳ autor: Graff-Guerrero A., González-Olvera J., Mendoza-Espinosa Y., Vaugier V., et al.2004JOURNAL OF AFFECTIVE DISORDERSWoS-id: 000221147500007
Scopus-id: 2-s2.0-1942470945
3840
202Differences in limbic metabolism according to variation of the 5HTTLPR polymorphism of serotonin transporter: A pilot pet study [Diferencias del metabolismo en estructuras límbicas de acuerdo a la variación alélica del polimorfismo 5HTTLP1ᵉʳ autor: Graff-Guerrero A., Alexánderson-Rosas E., Altamirano-Ley J., Estrada-Sanchez G., et al.2004SALUD MENTALScopus-id: 2-s2.0-11144353991
02
203Neurobiology of creativity: Preliminary results from a brain activation study [Neurobiología de la creatividad: Resultados preliminares de un estudio de activación cerebral]2ᵒ autor: Graff-Guerrero A., Chávez R.A., García-Reyna J.C., Vaugier V., et al.2004SALUD MENTALScopus-id: 2-s2.0-18844468299
029
204The applications of transcranial magnetic stimulation in psychiatry [Las aplicaciones de la estimulación magnética transcraneal en psiquiatría]Coautor y autor de correspondencia: Guerrero A.G., Jiménez-Genchi A., González-Olvera J.2002SALUD MENTALScopus-id: 2-s2.0-0036698666
01
205Transcranial magnetic repititive stimulation as an adjuvant of antidepressant drug treatmentCoautor y autor de correspondencia: Guerrero A.G., Jiménez-Genchi A., González-Olvera J.2001REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATIONWoS-id: 000174068400013
Scopus-id: 2-s2.0-0035721517
00
206Neurobiological perspective of schizophrenia [Perspectiva neurobiológica de la esquizofrenia]1ᵉʳ autor: Graff-Guerrero A., Apiquian R., Fresán A., García-Anaya M.2001SALUD MENTALScopus-id: 2-s2.0-0035704855
03
207Pain in psychiatry: Frequent cause of attention [El dolor en la psiquiatría: Causa frecuente de atención]1ᵉʳ autor y autor de correspondencia: Graff-Guerrero A.2001SALUD MENTALScopus-id: 2-s2.0-0035707714
02
208Effects of cypermethrin on the electroencephalographic activity of the Rat: A model of chemically induced seizures2ᵒ autor: Graff-Guerrero A., Condés-Lara M., Vega-Riveroll L.1999NEUROTOXICOLOGY AND TERATOLOGYWoS-id: 000080677700010
Scopus-id: 2-s2.0-0344848794
1114
Descargar PDF

Documentos no indexados (Humanindex)

# Título del documento ISSN Revista Año Fuente
Descargar PDF

No se encuentran registros en la base de datos de capítulos de libros (WoS y Scopus).

Descargar PDF

No se encuentran registros en la base de datos de obras con ISBN (Indautor).

Descargar PDF

No se encuentran registros en la base de datos de proyectos.

Descargar PDF

Participación en Comités de Tesis

# Título del documento Tipo de Tesis Sinodales Autores Año Entidad Url
1Asimetria hemisferica del flujo sanguineo cerebral en el trastorno depresivo mayor y caracterizacion de su modificacion como correlato de la respuesta antidepresivaTesis de EspecialidadARIEL GRAFF GUERRERO; Patron Vargas, Armando; 2006
Descargar PDF

No se encuentran registros en la base de datos de docencia impartida.

Descargar PDF

No se encuentran registros en la base de datos de patentes.

Descargar PDF

No se encuentran registros en la base de datos de libros completos (Humanindex).

Descargar PDF

Capítulos de libros (Humanindex)

# Título del libro Título del capítulo ISBN Editorial Año Fuente